Seufert, Lisa
Benzing, Thomas http://orcid.org/0000-0003-0512-1066
Ignarski, Michael http://orcid.org/0000-0001-6057-7694
Müller, Roman-Ulrich http://orcid.org/0000-0001-6910-0745
Article History
Accepted: 27 September 2021
First Online: 3 November 2021
Competing interests
: R.-U.M. has received honoraria for counselling and participation in advisory boards from Alnylam Pharmaceuticals. The other authors declare no competing interests.